Fulcrum Therapeutics Inc
NASDAQ:FULC

Watchlist Manager
Fulcrum Therapeutics Inc Logo
Fulcrum Therapeutics Inc
NASDAQ:FULC
Watchlist
Price: 3.32 USD -6.74% Market Closed
Market Cap: 207.2m USD
Have any thoughts about
Fulcrum Therapeutics Inc?
Write Note

Fulcrum Therapeutics Inc
PP&E Gross

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Fulcrum Therapeutics Inc
PP&E Gross Peer Comparison

Comparables:
JNJ
BMY
PFE
MRK
LLY

Competitive PP&E Gross Analysis
Latest Figures & CAGR of Competitors

Company PP&E Gross CAGR 3Y CAGR 5Y CAGR 10Y
Fulcrum Therapeutics Inc
NASDAQ:FULC
PP&E Gross
$10.8m
CAGR 3-Years
12%
CAGR 5-Years
1%
CAGR 10-Years
N/A
Johnson & Johnson
NYSE:JNJ
PP&E Gross
$20.5B
CAGR 3-Years
3%
CAGR 5-Years
3%
CAGR 10-Years
3%
Bristol-Myers Squibb Co
NYSE:BMY
PP&E Gross
$8.3B
CAGR 3-Years
6%
CAGR 5-Years
9%
CAGR 10-Years
7%
Pfizer Inc
NYSE:PFE
PP&E Gross
$19B
CAGR 3-Years
10%
CAGR 5-Years
5%
CAGR 10-Years
N/A
Merck & Co Inc
NYSE:MRK
PP&E Gross
$23.4B
CAGR 3-Years
8%
CAGR 5-Years
9%
CAGR 10-Years
6%
Eli Lilly and Co
NYSE:LLY
PP&E Gross
$16.2B
CAGR 3-Years
22%
CAGR 5-Years
14%
CAGR 10-Years
7%

See Also

What is Fulcrum Therapeutics Inc's PP&E Gross?
PP&E Gross
10.8m USD

Based on the financial report for Jun 30, 2024, Fulcrum Therapeutics Inc's PP&E Gross amounts to 10.8m USD.

What is Fulcrum Therapeutics Inc's PP&E Gross growth rate?
PP&E Gross CAGR 5Y
1%

Over the last year, the PP&E Gross growth was -25%. The average annual PP&E Gross growth rates for Fulcrum Therapeutics Inc have been 12% over the past three years , 1% over the past five years .

Back to Top